255 related articles for article (PubMed ID: 24890717)
1. Characterization of conventional and atypical receptors for the chemokine CCL2 on mouse leukocytes.
Ford LB; Cerovic V; Milling SW; Graham GJ; Hansell CA; Nibbs RJ
J Immunol; 2014 Jul; 193(1):400-11. PubMed ID: 24890717
[TBL] [Abstract][Full Text] [Related]
2. Atypical chemokine receptor ACKR2 mediates chemokine scavenging by primary human trophoblasts and can regulate fetal growth, placental structure, and neonatal mortality in mice.
Teoh PJ; Menzies FM; Hansell CA; Clarke M; Waddell C; Burton GJ; Nelson SM; Nibbs RJ
J Immunol; 2014 Nov; 193(10):5218-28. PubMed ID: 25297873
[TBL] [Abstract][Full Text] [Related]
3. The dual-function chemokine receptor CCR2 drives migration and chemokine scavenging through distinct mechanisms.
Shroka TM; Kufareva I; Salanga CL; Handel TM
Sci Signal; 2023 Jan; 16(770):eabo4314. PubMed ID: 36719944
[TBL] [Abstract][Full Text] [Related]
4. The CCL2/CCL7/CCL12/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system in microglia.
Popiolek-Barczyk K; Ciechanowska A; Ciapała K; Pawlik K; Oggioni M; Mercurio D; De Simoni MG; Mika J
Mol Cell Probes; 2020 Dec; 54():101671. PubMed ID: 33160071
[TBL] [Abstract][Full Text] [Related]
5. The atypical chemokine receptor ACKR2 drives pulmonary fibrosis by tuning influx of CCR2
Russo RC; Savino B; Mirolo M; Buracchi C; Germano G; Anselmo A; Zammataro L; Pasqualini F; Mantovani A; Locati M; Teixeira MM
Am J Physiol Lung Cell Mol Physiol; 2018 Jun; 314(6):L1010-L1025. PubMed ID: 29469612
[TBL] [Abstract][Full Text] [Related]
6. Atypical chemokine receptor ACKR2-V41A has decreased CCL2 binding, scavenging, and activation, supporting sustained inflammation and increased Alzheimer's disease risk.
Murcia JDG; Weinert A; Freitas CMT; Arens DK; Ferrel MN; Grose JH; Ridge PG; Wilson E; Kauwe JSK; Weber KS
Sci Rep; 2020 May; 10(1):8019. PubMed ID: 32415244
[TBL] [Abstract][Full Text] [Related]
7. Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes.
Kuscher K; Danelon G; Paoletti S; Stefano L; Schiraldi M; Petkovic V; Locati M; Gerber BO; Uguccioni M
Eur J Immunol; 2009 Apr; 39(4):1118-28. PubMed ID: 19291700
[TBL] [Abstract][Full Text] [Related]
8. The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury.
Woodcock TM; Frugier T; Nguyen TT; Semple BD; Bye N; Massara M; Savino B; Besio R; Sobacchi C; Locati M; Morganti-Kossmann MC
PLoS One; 2017; 12(11):e0188305. PubMed ID: 29176798
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of CCL2 and CCR2 in host defense to coronavirus infection.
Held KS; Chen BP; Kuziel WA; Rollins BJ; Lane TE
Virology; 2004 Nov; 329(2):251-60. PubMed ID: 15518805
[TBL] [Abstract][Full Text] [Related]
10. CCL3/CCR1 mediates CD14
Zhao X; Gu M; Xu X; Wen X; Yang G; Li L; Sheng P; Meng F
Osteoarthritis Cartilage; 2020 May; 28(5):613-625. PubMed ID: 32006659
[TBL] [Abstract][Full Text] [Related]
11. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
[TBL] [Abstract][Full Text] [Related]
12. Chemokine (C-C motif) ligand 2 and coronary artery disease: Tissue expression of functional and atypical receptors.
Hernández-Aguilera A; Fibla M; Cabré N; Luciano-Mateo F; Camps J; Fernández-Arroyo S; Martín-Paredero V; Menendez JA; Sirvent JJ; Joven J
Cytokine; 2020 Feb; 126():154923. PubMed ID: 31739217
[TBL] [Abstract][Full Text] [Related]
13. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair.
Lu H; Huang D; Ransohoff RM; Zhou L
FASEB J; 2011 Oct; 25(10):3344-55. PubMed ID: 21697550
[TBL] [Abstract][Full Text] [Related]
14. The Atypical Chemokine Receptor Ackr2 Constrains NK Cell Migratory Activity and Promotes Metastasis.
Hansell CAH; Fraser AR; Hayes AJ; Pingen M; Burt CL; Lee KM; Medina-Ruiz L; Brownlie D; Macleod MKL; Burgoyne P; Wilson GJ; Nibbs RJB; Graham GJ
J Immunol; 2018 Oct; 201(8):2510-2519. PubMed ID: 30158126
[TBL] [Abstract][Full Text] [Related]
15. Placental chemokine compartmentalisation: A novel mammalian molecular control mechanism.
Lee KM; Wilson GJ; Pingen M; Fukuoka A; Hansell CAH; Bartolini R; Medina-Ruiz L; Graham GJ
PLoS Biol; 2019 May; 17(5):e3000287. PubMed ID: 31141500
[TBL] [Abstract][Full Text] [Related]
16. CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels.
Maus UA; Wellmann S; Hampl C; Kuziel WA; Srivastava M; Mack M; Everhart MB; Blackwell TS; Christman JW; Schlöndorff D; Bohle RM; Seeger W; Lohmeyer J
Am J Physiol Lung Cell Mol Physiol; 2005 Feb; 288(2):L350-8. PubMed ID: 15516494
[TBL] [Abstract][Full Text] [Related]
17. Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection.
Jia T; Serbina NV; Brandl K; Zhong MX; Leiner IM; Charo IF; Pamer EG
J Immunol; 2008 May; 180(10):6846-53. PubMed ID: 18453605
[TBL] [Abstract][Full Text] [Related]
18. Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2
Takacs GP; Kreiger CJ; Luo D; Tian G; Garcia JS; Deleyrolle LP; Mitchell DA; Harrison JK
Front Immunol; 2022; 13():993444. PubMed ID: 36685592
[TBL] [Abstract][Full Text] [Related]
19. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.
Bursill CA; Castro ML; Beattie DT; Nakhla S; van der Vorst E; Heather AK; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1773-8. PubMed ID: 20702809
[TBL] [Abstract][Full Text] [Related]
20. NFATc1 releases BCL6-dependent repression of CCR2 agonist expression in peritoneal macrophages from Saccharomyces cerevisiae infected mice.
Busch R; Murti K; Liu J; Patra AK; Muhammad K; Knobeloch KP; Lichtinger M; Bonifer C; Wörtge S; Waisman A; Reifenberg K; Ellenrieder V; Serfling E; Avots A
Eur J Immunol; 2016 Mar; 46(3):634-46. PubMed ID: 26631626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
